Epicardial Fat: Physiological, Pathological, and Therapeutic Implications

Cardiology Research and Practice

Volumn 2016, Issue , 2016, Pages

  Salazar, Juan ^a   Luzardo, Eliana ^a   Mejías, José Carlos ^a   Rojas, Joselyn ^a,b   Ferreira, Antonio ^a,c   Rivas Ríos, José Ramón ^a   Bermúdez, Valmore ^a  

^a UNIVERSIDAD DEL ZULIA   (Venezuela)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Hospital Dr Manuel Noriega Trigo   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN;

ADIPOSE TISSUE; ARTERIAL STIFFNESS; ARTERY WALL; BLOOD VESSEL; CARDIAC MUSCLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL PROLIFERATION; CORONARY ARTERY; CORONARY ARTERY ATHEROSCLEROSIS; CYTOKINE RELEASE; EPICARDIAL FAT; EPICARDIUM; HUMAN; INSULIN SENSITIVITY; NONHUMAN; PROTEIN SYNTHESIS; REGULATORY MECHANISM; REVIEW; VASCULAR SMOOTH MUSCLE CELL; VASOCONSTRICTION; VASOCRINE REGULATION;

EID: 84973322890     PISSN: 20908016     EISSN: 20900597     Source Type: Journal    
DOI: 10.1155/2016/1291537     Document Type: Review

References (168)

1. P. Trayhurn and J. H. Beattie, "Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ, " Proceedings of the Nutrition Society, vol. 60, no. 3, pp. 329-339, 2001.
2. E. E. Kershaw and J. S. Flier, "Adipose tissue as an endocrine organ, " Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 6, pp. 2548-2556, 2004.
3. S. C. Gunawardana, "Benefits of healthy adipose tissue in the treatment of diabetes, " World Journal of Diabetes, vol. 5, no. 4, p. 420, 2014.
4. M. T. Hyvönen and K. L. Spalding, "Maintenance of white adipose tissue inman, " International Journal of Biochemistry and Cell Biology, vol. 56, pp. 123-132, 2014.
5. F. Badoud, M. Perreault, M. A. Zulyniak, and D. M. Mutch, "Molecular insights into the role of white adipose tissue in metabolically unhealthy normal weight and metabolically healthy obese individuals, " The FASEB Journal, vol. 29, no. 3, pp. 748-758, 2015.
6. M. J. P. Miguelsanz, W. C. Parra, G. V. Moreiras, and M. Garaulet, "Distribucíon regional de la grasa corporal. Uso de técnicas de imagen como herramienta de diagnóstico nutricional, " Nutricíon Hospitalaria, vol. 25, no. 2, pp. 207-223, 2010.
7. S. Roman, A. Agil, M. Peran et al., "Brown adipose tissue and novel therapeutic approaches to treat metabolic disorders, " Translational Research, vol. 165, no. 4, pp. 464-479, 2015.
8. J. B. Hansen and K. Kristiansen, "Regulatory circuits controlling white versus brown adipocyte differentiation, " Biochemical Journal, vol. 398, no. 2, pp. 153-168, 2006.
9. S. Kajimura, P. Seale, and B. M. Spiegelman, "Transcriptional control of brown fat development, " Cell Metabolism, vol. 11, no. 4, pp. 257-262, 2010.
10. N. Billon and C. Dani, "Developmental origins of the adipocyte lineage: new insights fromgenetics and genomics studies, " Stem Cell Reviews and Reports, vol. 8, no. 1, pp. 55-66, 2012.
11. R. Gómez, J. Conde, J. J. Gómez Reino, F. Lago, and O. Gualillo, "Las adipocinas: mediadores emergentes de la respuesta inmune y de la inflamacíon, " Reumatología Clínica, vol. 5, pp. 6-12, 2009.
12. M. A. Exley, L. Hand, D. O'Shea, and L. Lynch, "Interplay between the immune systemandadipose tissue inobesity, " Journal of Endocrinology, vol. 223, no. 2, pp. R41-R48, 2014.
13. J. Yang, J. Kang, and Y. Guan, "The mechanisms linking adiposopathy to type 2 diabetes, " Frontiers ofMedicine in China, vol. 7, no. 4, pp. 433-444, 2013.
14. M. Lima, N. Balladares, M. Mederico, and J. Nuccio, "Tejido adiposo epicárdico: un nuevo blanco terapéutico en obesidad" Síndrome Cardiometabólico, vol. 1, no. 2, pp. 45-48, 2011.
15. S. Limand J. B. Meigs, "Links between ectopic fat and vascular disease in humans, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 34, no. 9, pp. 1820-1826, 2014.
16. M. Bastien, P. Poirier, I. Lemieux, and J.-P. Després, "Overview of epidemiology and contribution of obesity to cardiovascular disease, " Progress in Cardiovascular Diseases, vol. 56, no. 4, pp. 369-381, 2014.
17. K. Nakamura, J. J. Fuster, and K. Walsh, "Adipokines: a link between obesity and cardiovascular disease, " Journal of Cardiology, vol. 63, no. 4, pp. 250-259, 2014.
18. C. S. Fox, J. M. Massaro, U. Hoffmann et al., "Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the framingham heart study, " Circulation, vol. 116, no. 1, pp. 39-48, 2007.
19. G. Iacobellis, Obesity and Cardiovascular Disease, Oxford University Press, Oxford, UK, 2009.
20. S. W. Rabkin, "Epicardial fat: properties, function and relationship to obesity, " Obesity Reviews, vol. 8, no. 3, pp. 253-261, 2007.
21. G. Iacobellis, A. E. Malavazos, and M. M. Corsi, "Epicardial fat: from the biomolecular aspects to the clinical practice, " International Journal of Biochemistry and Cell Biology, vol. 43, no. 12, pp. 1651-1654, 2011.
22. G. Iacobellis and G. Barbaro, "The double role of epicardial adipose tissue as pro-and anti-inflammatory organ, " Hormone and Metabolic Research, vol. 40, no. 7, pp. 442-445, 2008.
23. A. S. Cikim, E. Topal, M. Harputluoglu et al., "Epicardial adipose tissue, hepatic steatosis and obesity, " Journal of Endocrinological Investigation, vol. 30, no. 6, pp. 459-464, 2007.
24. G. Iacobellis, "Epicardial adipose tissue in endocrine andmetabolic diseases, " Endocrine, vol. 46, no. 1, pp. 8-15, 2014.
25. G. Iacobellis, "Epicardial and pericardial fat: close, but very different, " Obesity, vol. 17, no. 4, p. 625, 2009.
26. M. ç etin, S. A. Kocaman, M. E. Durakôglugil et al., "Effect of epicardial adipose tissue on diastolic functions and left atrial dimension in untreated hypertensive patients with normal systolic function, " Journal of Cardiology, vol. 61, no. 5, pp. 359-364, 2013.
27. T. Mazurek, L. Zhang, A. Zalewski et al., "Human epicardial adipose tissue is a source of inflammatory mediators, " Circulation, vol. 108, no. 20, pp. 2460-2466, 2003.
28. M. Lima and G. Iacobellis, "Grasa epicárdica: Una nueva herramienta para la evaluacíon del riesgo cardiometabólico, " Hipertensíon y Riesgo Vascular, vol. 28, no. 2, pp. 63-68, 2011.
29. M. Harms and P. Seale, "Brown and beige fat: development, function and therapeutic potential, " Nature Medicine, vol. 19, no. 10, pp. 1252-1263, 2013.
30. J. H. Park, W. Hur, and S. B. Lee, "Intricate transcriptional networks of classical brown and beige fat cells, " Frontiers in Endocrinology, vol. 6, article 124, 2015.
31. B. Cannon and J. Nedergaard, "Brown adipose tissue: function and physiological significance, " Physiological Reviews, vol. 84, no. 1, pp. 277-359, 2004.
32. H. S. Sacks, J. N. Fain, B. Holman et al., "Uncoupling protein-1 and related messenger ribonucleic acids in human epicardial and other adipose tissues: epicardial fat functioning as brown fat, "The Journal of Clinical Endocrinology&Metabolism, vol. 94, no. 9, pp. 3611-3615, 2009.
33. T. P. Fitzgibbons and M. P. Czech, "Epicardial and perivascular adipose tissues and their influence on cardiovascular disease: basic mechanisms and clinical associations, " Journal of the AmericanHeartAssociation, vol. 3, no. 2, Article IDe000582, pp. 1-15, 2014.
34. N. Lanthier and I. A. Leclercq, "Adipose tissues as endocrine target organs, " Best Practice and Research: Clinical Gastroenterology, vol. 28, no. 4, pp. 545-558, 2014.
35. J. Wu, P. Cohen, and B. M. Spiegelman, "Adaptive thermogenesis in adipocytes: is beige the newbrown"Genes andDevelopment, vol. 27, no. 3, pp. 234-250, 2013.
36. J. Himms-Hagen, "Brown adipose tissue thermogenesis: interdisciplinary studies, " The FASEB Journal, vol. 4, no. 11, pp. 2890-2898, 1990.
37. H. S. Sacks and J. N. Fain, "Human epicardial fat: what is new and what is missing" Clinical and Experimental Pharmacology and Physiology, vol. 38, no. 12, pp. 879-887, 2011.
38. J. M. Marchington and C. M. Pond, "Site-specific properties of pericardial and epicardial adipose tissue: the effects of insulin and high-fat feeding on lipogenesis and the incorporation of fatty acids in vitro, " International Journal of Obesity, vol. 14, no. 12, pp. 1013-1022, 1990.
39. G. I. Shulman, "Cellular mechanisms of insulin resistance, " The Journal of Clinical Investigation, vol. 106, no. 2, pp. 171-176, 2000.
40. J. M. Friedman, "Obesity in the new millennium, " Nature, vol. 404, no. 6778, pp. 632-634, 2000.
41. S. Greulich, W. J. Y. Chen, B. Maxhera et al., "Cardioprotective properties of omentin-1 in type 2 diabetes: evidence from clinical and in vitro studies, " PLoS ONE, vol. 8, no. 3, Article ID e59697, 2013.
42. M. S. Jamaluddin, S. M. Weakley, Q. Yao, and C. Chen, "Resistin: functional roles and therapeutic considerations for cardiovascular disease, " British Journal of Pharmacology, vol. 165, no. 3, pp. 622-632, 2012.
43. G. Sommer, A. Garten, S. Petzold et al., "Visfatin/PBEF/Nampt: structure, regulation and potential function of a novel adipokine, " Clinical Science, vol. 115, no. 1-2, pp. 13-23, 2008.
44. G. Iacobellis, D. Pistilli, M. Gucciardo et al., "Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease, " Cytokine, vol. 29, no. 6, pp. 251-255, 2005.
45. S. Cherian, G. D. Lopaschuk, and E. Carvalho, "Cellular crosstalk between epicardial adipose tissue and myocardium in relation to the pathogenesis of cardiovascular disease, " American Journal of Physiology-Endocrinology and Metabolism, vol. 303, no. 8, pp. E937-E949, 2012.
46. Y. Hirata, M. Tabata, H. Kurobe et al., "Coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue, " Journal of the American College of Cardiology, vol. 58, no. 3, pp. 248-255, 2011.
47. N. Ouchi, K. Ohashi, R. Shibata, and T. Murohara, "Adipocytokines and obesity-linked disorders, " Nagoya Journal of Medical Science, vol. 74, no. 1-2, pp. 19-30, 2012.
48. H. K. Wong, F. Tang, T. T. Cheung, and B. M. Y. Cheung, "Adrenomedullin and diabetes, " World Journal of Diabetes, vol. 5, no. 3, pp. 364-371, 2014.
49. F. Sánchez, R. García, F. Alarcón, and Y. M. Cruz, "Adipocinas, tejido adiposo y su relacíon con células del sistema inmune, " Gaceta Médica de México, vol. 141, no. 6, pp. 505-512, 2005.
50. T. Yamauchi, J. Kamon, H. Waki et al., "The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity, " Nature Medicine, vol. 7, no. 8, pp. 941-946, 2001.
51. Y. Ichiki, K. Kitamura, K. Kangawa, M. Kawamoto, H. Matsuo, and T. Eto, "Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma, " FEBS Letters, vol. 338, no. 1, pp. 6-10, 1994.
52. Y. Shimekake, K. Nagata, S. Ohta et al., "Adrenomedullin stimulates two signal transduction pathways, cAMP accumulation and C2+ mobilization, in bovine aortic endothelial cells, " The Journal of Biological Chemistry, vol. 270, no. 9, pp. 4412-4417, 1995.
53. T. Eto, K. Kitamura, and J. Kato, "Biological and clinical roles of adrenomedullin in circulation control and cardiovascular diseases, " Clinical and Experimental Pharmacology and Physiology, vol. 26, no. 5-6, pp. 371-380, 1999.
54. A. R. Marks, "Calcium cycling proteins and heart failure:mechanisms and therapeutics, " The Journal of Clinical Investigation, vol. 123, no. 1, pp. 46-52, 2013.
55. M. M. Petrovic, K. Vales, B. Putnikovic, V. Djulejic, and D. M. Mitrovic, "Ryanodine receptors, voltage-gated calcium channels and their relationship with protein kinase A in the myocardium, " Physiological Research, vol. 57, no. 2, pp. 141-149, 2008.
56. K. Keef, J. Hume, and J. Zhong, "Regulation of cardiac and smooth muscle Ca2+channels (Ca1. 2a, b) by protein kinases, " American Journal of Physiology-Cell Physiology, vol. 281, no. 6, pp. C1743-C1756, 2001.
57. H. K. Wong, T. T. Cheung, and B. M. Y. Cheung, "Adrenomedullin and cardiovascular diseases, " JRSM Cardiovascular Disease, vol. 1, no. 5, pp. 1-7, 2012.
58. M. Lima, C. Torres, F. Rosa, E. Romero, E. Guerra, and J. Zerpa, "Adrenomedulina: más que una simple hormona" Revista Venezolana de Endocrinología y Metabolismo, vol. 1, pp. 4-11, 2011.
59. L. Lin and A. A. Knowlton, "Innate immunity and cardiomyocytes in ischemic heart disease, " Life Sciences, vol. 100, no. 1, pp. 1-8, 2014.
60. M. Lima, "Propiedades pro-aterogénicas del tejido adiposo epicárdico, " Atherosclerosis Today, vol. 1, pp. 15-17, 2011.
61. Y. S. Kang, "Obesity associated hypertension: new insights into mechanism, " Electrolyte and Blood Pressure, vol. 11, no. 2, pp. 46-52, 2013.
62. A. R. Baker, A. L. Harte, N. Howell et al., "Epicardial adipose tissue as a source of nuclear factor-kappaB and c-Jun N-terminal kinase mediated inflammation in patients with coronary artery disease, " The Journal of Clinical Endocrinology & Metabolism, vol. 94, no. 1, pp. 261-267, 2009.
63. M. Klouche, S. Bhakdi, M. Hemmes, and S. Rose-John, "Novel path to activation of vascular smooth muscle cells: upregulation of gp130 creates an autocrine activation loop by IL-6 and its soluble receptor, "TheJournal of Immunology, vol. 163, no. 8, pp. 4583-4589, 1999.
64. J. J. Senn, P. J. Klover, I. A. Nowak, and R. A. Mooney, "Interleukin-6 induces cellular insulin resistance in hepatocytes, " Diabetes, vol. 51, no. 12, pp. 3391-3399, 2002.
65. M. Matsuda and I. Shimomura, "Roles of oxidative stress, adiponectin, and nuclear hormone receptors in obesityassociated insulin resistance and cardiovascular risk, " Hormone Molecular Biology and Clinical Investigation, vol. 19, no. 2, pp. 75-88, 2014.
66. A. T. Turer and P. E. Scherer, "Adiponectin: mechanistic insights and clinical implications, " Diabetologia, vol. 55, pp. 2319-2326, 2012.
67. N. Elissondo, L. G. Rosso, P. Maidana, and F. Brites, "Adiponectin: an adipocytokine with multiple protective functions, " Acta Bioquimica Clinica Latinoamericana, vol. 42, no. 1, pp. 17-33, 2008.
68. T. Yamauchi, J. Kamon, Y. Minokoshi et al., "Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase, " Nature Medicine, vol. 8, no. 11, pp. 1288-1295, 2002.
69. T. Yamauchi and T. Kadowaki, "Adiponectin receptor as a key player in healthy longevity and obesity-related diseases, " Cell Metabolism, vol. 17, no. 2, pp. 185-196, 2013.
70. J.-P. Bastard, M. Maachi, C. Lagathu et al., "Recent advances in the relationship between obesity, inflammation, and insulin resistance, " European Cytokine Network, vol. 17, no. 1, pp. 4-12, 2006.
71. W. Xi, H. Satoh, H. Kase, K. Suzuki, and Y. Hattori, "Stimulated HSP90 binding to eNOS and activation of the PI3-Akt pathway contribute to globular adiponectin-induced NO production: vasorelaxation in response to globular adiponectin, " Biochemical and Biophysical Research Communications, vol. 332, no. 1, pp. 200-205, 2005.
72. G. Fésüs, G. Dubrovska, K. Gorzelniak et al., "Adiponectin is a novel humoral vasodilator, " Cardiovascular Research, vol. 75, no. 4, pp. 719-727, 2007.
73. Y. Li, C. Jiang, X. Wang, Y. Zhang, S. Shibahara, and K. Takahashi, "Adrenomedullin is a novel adipokine: adrenomedullin in adipocytes and adipose tissues, " Peptides, vol. 28, no. 5, pp. 1129-1143, 2007.
74. Á. Fortis, R. García, C. Maldonado, F. Alarcón, and M. Cruz, "El papel de la inmunidad innata en la obesidad, " Salud Pública de México, vol. 54, pp. 171-177, 2012.
75. M. Pal, M. A. Febbraio, and M. Whitham, "From cytokine to myokine: the emerging role of interleukin-6 in metabolic regulation, " Immunology andCell Biology, vol. 92, no. 4, pp. 331-339, 2014.
76. H. Lee, I. S. Lee, and R. Choue, "Obesity, inflammation and diet, " Pediatric Gastroenterology, Hepatology & Nutrition, vol. 16, no. 3, pp. 143-152, 2013.
77. P. M. Ridker, N. Rifai, M. J. Stampfer, and C. H. Hennekens, "Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthymen, " Circulation, vol. 101, no. 15, pp. 1767-1772, 2000.
78. D. X. Zhang, F.-X. Yi, A.-P. Zou, and P.-L. Li, "Role of ceramide in TNF-induced impairment of endotheliumdependent vasorelaxation in coronary arteries, " American Journal of Physiology-Heart and Circulatory Physiology, vol. 283, no. 5, pp. H1785-H1794, 2002.
79. H. Zhang, Y. Park, J. Wu et al., "Role of TNF in vascular dysfunction, " Clinical Science, vol. 116, no. 3, pp. 219-230, 2009.
80. X. U. Haiyan, J. Hirosumi, K. Teoman Uysal, A. Deniz Guler, and G. S. Hotamisligil, "Exclusive action of transmembrane TNF in adipose tissue leads to reduced adipose mass and local but not systemic insulin resistance, " Endocrinology, vol. 143, no. 4, pp. 1502-1511, 2002.
81. N. Maenhaut and J. Van deVoorde, "Regulation of vascular tone by adipocytes, " BMC Medicine, vol. 9, article 25, 12 pages, 2011.
82. G. A. Payne, M. C. Kohr, and J. D. Tune, "Epicardial perivascular adipose tissue as a therapeutic target in obesity-related coronary artery disease, " British Journal of Pharmacology, vol. 165, no. 3, pp. 659-669, 2012.
83. J. S. Yudkin, E. Eringa, and C. D. A. Stehouwer, "'Vasocrine' signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease, " The Lancet, vol. 365, no. 9473, pp. 1817-1820, 2005.
84. J. S. Yudkin, "Inflammation, obesity, and the metabolic syndrome, " Hormone and Metabolic Research, vol. 39, no. 10, pp. 707-709, 2007.
85. C. M. B. de Oliveira, R. K. Sakata, A. M. Issy, L. R. Gerola, and R. Salomão, "Citocinas y dolor, " Revista Brasileira de Anestesiologia, vol. 61, no. 2, pp. 137-142, 2011.
86. P. Iozzo, "Myocardial, perivascular, and epicardial fat, " Diabetes Care, vol. 34, no. 2, pp. S371-S379, 2011.
87. S. Rajsheker, D. Manka, A. L. Blomkalns, T. K. Chatterjee, L. L. Stoll, and N. L. Weintraub, "Crosstalk between perivascular adipose tissue and blood vessels, " Current Opinion in Pharmacology, vol. 10, no. 2, pp. 191-196, 2010.
88. J. L. S. Esguerra, I. G. Mollet, V. A. Salunkhe, A. Wendt, and L. Eliasson, "Regulation of pancreatic beta cell stimulus-secretion coupling by microRNAs, " Genes, vol. 5, no. 4, pp. 1018-1031, 2014.
89. B. Cortés Morales, "Síndrome metabólico y antipsicóticos de segunda generacíon, " Revista de la Asociacíon Española de Neuropsiquiatría, vol. 31, no. 2, pp. 303-320, 2011.
90. P. Newsholme, V. Cruzat, F. Arfuso, and K. Keane, "Nutrient regulation of insulin secretion and action, " Journal of Endocrinology, vol. 221, no. 3, pp. R105-R120, 2014.
91. B. Cheatham and C. R. Kahn, "Insulin action and the insulin signaling network, " Endocrine Reviews, vol. 16, no. 2, pp. 117-142, 1995.
92. D. Le Roith and Y. Zick, "Recent advances in our understanding of insulin action and insulin resistance, " Diabetes Care, vol. 24, no. 3, pp. 588-597, 2001.
93. C. E. Pinzón, M. L. Serrano, and M. C. Sanabria, "Role of phosphatidylinositol 3-kinase pathway (PI3K/Akt) in humans, " Revista Ciencias de la Salud, vol. 7, no. 2, pp. 47-66, 2009.
94. M. Sadagurski, G. Weingarten, C. J. Rhodes, M. F. White, and E. Wertheimer, "Insulin receptor substrate 2 plays diverse cellspecific roles in the regulation of glucose transport, " The Journal of Biological Chemistry, vol. 280, no. 15, pp. 14536-14544, 2005.
95. J. Rojas, V. Bermúdez, E. Leal et al., "Insulinorresistencia e hiperinsulinemia como factores de riesgo para enfermedad cardiovascular, " Archivos Venezolanos de Farmacología y Terapéutica, vol. 27, no. 1, pp. 30-40, 2008.
96. G. Iacobellis, C. R. T. di Gioia, D. Cotesta et al., "Epicardial adipose tissue adiponectin expression is related to intracoronary adiponectin levels, " Hormone and Metabolic Research, vol. 41, no. 3, pp. 227-231, 2009.
97. G. Iacobellis, C. R. diGioia, M. diVito et al., "Epicardial adipose tissue and intracoronary adrenomedullin levels in coronary artery disease, "Hormone andMetabolic Research, vol. 41, no. 12, pp. 855-860, 2009.
98. K. K. Y. Cheng, K. S. L. Lam, Y. Wang et al., "Adiponectininduced endothelial nitric oxide synthase activation and nitric oxide production are mediated by APPL1 in endothelial cells, " Diabetes, vol. 56, no. 5, pp. 1387-1394, 2007.
99. S. S. Deepa and L. Q. Dong, "Appl1: role in adiponectin signaling and beyond, " American Journal of Physiology-Endocrinology and Metabolism, vol. 296, no. 1, pp. E22-E36, 2009.
100. T. Maia, R. Roncon, and A. Leite, "Acções Cardiovasculares da Adiponectina: implicações Fisiopatológicas, " Revista Portuguesa de Cardiologia, vol. 27, pp. 1431-1450, 2008.
101. F. Manzur, C. Alvear, and A. N. Alayón, "Adipocitos, obesidad visceral, inflamacíon y enfermedad cardiovascular, " Revista Colombiana de Cardiología, vol. 17, no. 5, pp. 207-213, 2010.
102. G. R. Hajer, T. W. van Haeften, and F. L. J. Visseren, "Adipose tissue dysfunction in obesity, diabetes, and vascular diseases, " European Heart Journal, vol. 29, no. 24, pp. 2959-2971, 2008.
103. T. Suganami, J. Nishida, and Y. Ogawa, "A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor , " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 10, pp. 2062-2068, 2005.
104. T. Suganami, K. Tanimoto-Koyama, J. Nishida et al., "Role of the Toll-like receptor 4/NFB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 1, pp. 84-91, 2007.
105. P. A. Permana, C. Menge, and P. D. Reaven, "Macrophagesecreted factors induce adipocyte inflammation and insulin resistance, " Biochemical and Biophysical Research Communications, vol. 341, no. 2, pp. 507-514, 2006.
106. H. Ruan, N. Hacohen, T. R. Golub, L. Van Parijs, and H. F. Lodish, "Tumor necrosis factor suppresses adipocytespecific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factorB activation by TNF is obligatory, " Diabetes, vol. 51, no. 5, pp. 1319-1336, 2002.
107. J. Niu and P. E. Kolattukudy, "Role ofMCP-1 in cardiovascular disease: molecularmechanisms and clinical implications, " Clinical Science, vol. 117, no. 3, pp. 95-109, 2009.
108. E. Golia, G. Limongelli, F. Natale et al., "Adipose tissue and vascular inflammation in coronary artery disease, " World Journal of Cardiology, vol. 6, no. 7, pp. 539-554, 2014.
109. G. Iacobellis, N. Singh, and A. M. Sharma, "Cardiac adiposity and cardiovascular risk: potential role of epicardial adipose tissue, " Current Cardiology Reviews, vol. 3, no. 1, pp. 11-14, 2007.
110. T. Horiuchi, H. Mitoma, S.-I. Harashima, H. Tsukamoto, and T. Shimoda, "Transmembrane TNF: structure, function and interaction with anti-TNF agents, " Rheumatology, vol. 49, no. 7, pp. 1215-1228, 2010.
111. J. M. F. Lona, M. S. Martínez, G. V. Alarcón, A. B. Rodas, and J. R. Bello, "El factor de necrosis tumoral (TNF) en las enfermedades cardiovasculares: biología molecular y genética, " Gaceta Médica de México, vol. 149, pp. 521-530, 2013.
112. H. Wajant, K. Pfizenmaier, and P. Scheurich, "Tumor necrosis factor signaling, " Cell Death and Differentiation, vol. 10, no. 1, pp. 45-65, 2003.
113. G. Chen and D. V. Goeddel, "TNF-R1 signaling: a beautiful pathway, " Science, vol. 296, no. 5573, pp. 1634-1635, 2002.
114. R. Muniyappa and J. R. Sowers, "Role of insulin resistance in endothelial dysfunction, " Reviews in Endocrine and Metabolic Disorders, vol. 14, no. 1, pp. 5-12, 2013.
115. A. G. Turjanski, J. P. Vaqué, and J. S. Gutkind, "MAP kinases and the control of nuclear events, " Oncogene, vol. 26, no. 22, pp. 3240-3253, 2007.
116. H. Gehart, S. Kumpf, A. Ittner, and R. Ricci, "MAPK signalling in cellular metabolism: stress or wellness" EMBO Reports, vol. 11, no. 11, pp. 834-840, 2010.
117. Z. Liu and W. Cao, "P38 mitogen-activated protein kinase: a critical node linking insulin resistance and cardiovascular diseases in type 2 diabetes mellitus, " Endocrine, Metabolic and Immune Disorders-Drug Targets, vol. 9, no. 1, pp. 38-46, 2009.
118. G. M. Rubanyi and M. A. Polokoff, "Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology, " Pharmacological Reviews, vol. 46, no. 3, pp. 325-415, 1994.
119. A. Ergul, "Endothelin-1 and endothelin receptor antagonists as potential cardiovascular therapeutic agents, " Pharmacotherapy, vol. 22, no. 1 I, pp. 54-65, 2002.
120. E. R. Levin, "Endothelins, " New England Journal of Medicine, vol. 333, no. 6, pp. 356-363, 1995.
121. M. Baltazares, H. Rodríguez, J. Ortega, A. Sotres, and M. E. Baltazares, "Sistema endotelina, " Revista del Instituto Nacional de Enfermedades Respiratorias México, vol. 18, pp. 308-320, 2005.
122. R. I. Meijer, E. H. Serne, Y. M. Smulders, V. W. M. van Hinsbergh, J. S. Yudkin, and E. C. Eringa, "Perivascular adipose tissue and its role in type 2 diabetes and cardiovascular disease, " Current Diabetes Reports, vol. 11, no. 3, pp. 211-217, 2011.
123. S. Yusuf, S. Hawken, S. Ôunpuu et al., "Obesity and the risk of myocardial infarction in 27. 000 participants from 52 countries: a case-control study, " The Lancet, vol. 366, no. 9497, pp. 1640-1649, 2005.
124. J. M. McGavock, R. G. Victor, R. H. Unger, and L. S. Szczepaniak, "Adiposity of the heart, revisited, " Annals of Internal Medicine, vol. 144, no. 7, pp. 517-524, 2006.
125. G. Iacobellis, M. C. Ribaudo, A. Zappaterreno, C. V. Iannucci, and F. Leonetti, "Relation between epicardial adipose tissue and left ventricular mass, " American Journal of Cardiology, vol. 94, no. 8, pp. 1084-1087, 2004.
126. M.-K. Kim, K. Tanaka, M.-J. Kim et al., "Comparison of epicardial, abdominal and regional fat compartments in response to weight loss, " Nutrition, Metabolism and Cardiovascular Diseases, vol. 19, no. 11, pp. 760-766, 2009.
127. S. S. Salami, M. Tucciarone, R. Bess et al., "Race and epicardial fat: the impact of anthropometric measurements, percent body fat and sex, " Ethnicity and Disease, vol. 23, no. 3, pp. 281-285, 2013.
128. A. G. Bertaso, D. Bertol, B. B. Duncan, and M. Foppa, "Epicardial fat: definition, measurements and systematic review of main outcomes, " Arquivos Brasileiros de Cardiologia, vol. 101, no. 1, pp. e18-e28, 2013.
129. G. Iacobellis, F. Assael, M. C. Ribaudo et al., "Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction, " Obesity Research, vol. 11, no. 2, pp. 304-310, 2003.
130. G. A. Rosito, J. M. Massaro, U. Hoffmann et al., "Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study, " Circulation, vol. 117, no. 5, pp. 605-613, 2008.
131. S. Abbara, J. C. Desai, R. C. Cury, J. Butler, K. Nieman, and V. Reddy, "Mapping epicardial fat with multi-detector computed tomography to facilitate percutaneous transepicardial arrhythmia ablation, " European Journal of Radiology, vol. 57, no. 3, pp. 417-422, 2006.
132. K. A. Britton and C. S. Fox, "Perivascular adipose tissue and vascular disease, " Clinical Lipidology, vol. 6, no. 1, pp. 79-91, 2011.
133. D. J. Pennell, "Cardiovascular magnetic resonance, " Circulation, vol. 121, no. 5, pp. 692-705, 2010.
134. M. Tachibana, T. Miyoshi, K. Osawa et al., "Measurement of epicardial fat thickness by transthoracic echocardiography for predicting high-risk coronary artery plaques, " Heart andVessels, 2016.
135. T. Ito, K. Nasu, M. Terashima et al., "Theimpact of epicardial fat volume on coronary plaque vulnerability: insight from optical coherence tomography analysis, " European Heart Journal Cardiovascular Imaging, vol. 13, no. 5, pp. 408-415, 2012.
136. A. Yerramasu, D. Dey, S. Venuraju et al., "Increased volume of epicardial fat is an independent risk factor for accelerated progression of sub-clinical coronary atherosclerosis, " Atherosclerosis, vol. 220, no. 1, pp. 223-230, 2012.
137. N. Alexopoulos, D. S. McLean, M. Janik, C. D. Arepalli, A. E. Stillman, and P. Raggi, "Epicardial adipose tissue and coronary artery plaque characteristics, " Atherosclerosis, vol. 210, no. 1, pp. 150-154, 2010.
138. A. A. Mahabadi, M. H. Berg, N. Lehmann et al., "Association of epicardial fat with cardiovascular risk factors and incident myocardial infarction in the general population: theHeinzNixdorf recall study, " Journal of the American College of Cardiology, vol. 61, no. 13, pp. 1388-1395, 2013.
139. K. Okada, S. Ohshima, S. Isobe et al., "Epicardial fat volume correlates with severity of coronary artery disease in nonobese patients, " Journal of Cardiovascular Medicine, vol. 15, no. 5, pp. 384-390, 2014.
140. K. Iwasaki, T. Matsumoto, H. Aono, H. Furukawa, and M. Samukawa, "Relationship between epicardial fat measured by 64-multidetector computed tomography and coronary artery disease, " Clinical Cardiology, vol. 34, no. 3, pp. 166-171, 2011.
141. M. B. Demircelik, O. C. Yilmaz, O. M. Gurel et al., "Epicardial adipose tissue and pericoronary fat thickness measured with 64-multidetector computed tomography: potential predictors of the severity of coronary artery disease, " Clinics, vol. 69, no. 6, pp. 388-392, 2014.
142. K. Yamashita, M. H. W. Yamamoto, S. Ebara et al., "Association between increased epicardial adipose tissue volume and coronary plaque composition, " Heart and vessels, vol. 29, no. 5, pp. 569-577, 2014.
143. Y.-J. Geng, L. E. Henderson, E. B. Levesque, M. Muszynski, and P. Libby, "Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smoothmuscle cells, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 17, no. 10, pp. 2200-2208, 1997.
144. M. Echavarría-Pinto, L. Hernando, and F. Alfonso, "From the epicardial adipose tissue to vulnerable coronary plaques, " World Journal of Cardiology, vol. 5, no. 4, pp. 68-74, 2013.
145. G. Iacobellis, M. C. Ribaudo, F. Assael et al., "Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk, " Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 11, pp. 5163-5168, 2003.
146. H. Yorgun, U. Canpolat, T. Hazirolan et al., "Increased epicardial fat tissue is a marker of metabolic syndrome in adult patients, " International Journal of Cardiology, vol. 165, no. 2, pp. 308-313, 2013.
147. K. Okyay, A. S. Balcioglu, Y. Tavil, G. Tacoy, S. Turkoglu, and A. Abaci, "A relationship between echocardiographic subepicardial adipose tissue and metabolic syndrome, " International Journal of Cardiovascular Imaging, vol. 24, no. 6, pp. 577-583, 2008.
148. B. Kaya, B. C. Kaya, E. Y. Karakas et al., "Usefulness of the epicardial fat tissue thickness as a diagnostic criterion for geriatric patientswithmetabolic syndrome, " Journal ofGeriatric Cardiology, vol. 12, no. 4, pp. 373-377, 2015.
149. M. J. FernándezMuñoz, L. Basurto Acevedo, N. Córdova Pérez et al., "Epicardial adipose tissue is associated with visceral fat, metabolic syndrome, and insulin resistance in menopausal women, " Revista Espanola de Cardiologia, vol. 67, no. 6, pp. 436-441, 2014.
150. N. Klöting and M. Blüher, "Adipocyte dysfunction, inflammation and metabolic syndrome, " Reviews in Endocrine andMetabolic Disorders, vol. 15, no. 4, pp. 277-287, 2014.
151. B. Akyol, M. Boyraz, and C. Aysoy, "Relationship of epicardial adipose tissue thickness with early indicators of atherosclerosis and cardiac functional changes in obese adolescents with metabolic syndrome, " Journal of Clinical Research in Pediatric Endocrinology, vol. 5, no. 3, pp. 156-163, 2013.
152. F.-Z. Wu, K.-J. Chou, Y.-L. Huang, and M.-T. Wu, "The relation of location-specific epicardial adipose tissue thickness and obstructive coronary artery disease: systemic review and metaanalysis of observational studies, " BMC Cardiovascular Disorders, vol. 14, article 62, 2014.
153. T. G. Yañez-Rivera, M. A. Baños-Gonzalez, J. L. Ble-Castillo, M. E. Torres-Hernandez, J. E. Torres-Lopez, and G. Borrayo-Sanchez, "Relationship between epicardial adipose tissue, coronary artery disease and adiponectin in a Mexican population, " Cardiovascular Ultrasound, vol. 12, article 35, 2014.
154. Y. Hirata, H. Yamada, K. Kusunose et al., "Clinical utility of measuring epicardial adipose tissue thickness with echocardiography using a high-frequency linear probe in patients with coronary artery disease, " Journal of the American Society of Echocardiography, vol. 28, no. 10, pp. 1240-1246, 2015.
155. F. A. Picard, P. Gueret, J.-P. Laissy et al., "Epicardial adipose tissue thickness correlates with the presence and severity of angiographic coronary artery disease in stable patients with chest pain, " PLoS ONE, vol. 9, no. 10, Article IDe110005, 2014.
156. S. D. Pierdomenico, A. M. Pierdomenico, F. Cuccurullo, and G. Iacobellis, "Meta-analysis of the relation of echocardiographic epicardial adipose tissue thickness and the metabolic syndrome, " American Journal of Cardiology, vol. 111, no. 1, pp. 73-78, 2013.
157. J. H. Park, Y. S. Park, Y. J. Kim et al., "Effects of Statins on the epicardial fat thickness in patients with coronary artery stenosis underwent percutaneous coronary intervention: comparison of Atorvastatin with Simvastatin/Ezetimibe, " Journal of Cardiovascular Ultrasound, vol. 18, no. 4, pp. 121-126, 2010.
158. H. S. Sacks, J. N. Fain, P. Cheema et al., "Inflammatory genes in epicardial fat contiguous with coronary atherosclerosis in the metabolic syndrome and type 2 diabetes: changes associated with pioglitazone, " Diabetes Care, vol. 34, no. 3, pp. 730-733, 2011.
159. M. M. Lima-Martínez, M. Paoli, M. Rodney et al., "Effect of sitagliptin on epicardial fat thickness in subjects with type 2 diabetes and obesity: a pilot study, " Endocrine, vol. 51, no. 3, pp. 448-455, 2016.
160. B. Elisha, M. Azar, N. Taleb, S. Bernard, G. Iacobellis, and R. Rabasa-Lhoret, "Body composition and epicardial fat in type 2 diabetes patients following insulin detemir versus insulin glargine initiation, " Hormone and Metabolic Research, vol. 48, no. 1, pp. 42-47, 2016.
161. M.-K. Kim, T. Tomita, M.-J. Kim, H. Sasai, S. Maeda, and K. Tanaka, "Aerobic exercise training reduces epicardial fat in obese men, " Journal of Applied Physiology, vol. 106, no. 1, pp. 5-11, 2009.
162. D. Steinberg, "The statins in preventive cardiology, " New England Journal of Medicine, vol. 359, no. 14, pp. 1426-1427, 2008.
163. K. K. Ray and C. P. Cannon, "The potential relevance of the multiple lipid-independent (pleiotropic) effects of statins in the management of acute coronary syndromes, " Journal of the American College of Cardiology, vol. 46, no. 8, pp. 1425-1433, 2005.
164. D. Echeverri, L. Buitrago, and F. Montes, "Efectos pleiotrópicos de las estatinas. Características farmacológicas útiles en la prevencíon, tratamiento y regresíon de la enfermedad cardiovascular, " Revista Colombiana de Cardiología, vol. 12, no. 3, pp. 103-112, 2005.
165. K.-I. Cho, B.-J. Kim, T.-J. Cha, J.-H. Heo, H.-S. Kim, and J.-W. Lee, "Impact of duration and dosage of statin treatment and epicardial fat thickness on the recurrence of atrial fibrillation after electrical cardioversion, " Heart and Vessels, vol. 30, no. 4, pp. 490-497, 2014.
166. H. Acet, F. Ertaş, M. A. Akil et al., "New inflammatory predictors for non-valvular atrial fibrillation: echocardiographic epicardial fat thickness and neutrophil to lymphocyte ratio, " International Journal of Cardiovascular Imaging, vol. 30, no. 1, pp. 81-89, 2014.
167. G. Iacobellis, M. Mohseni, and S. Bianco, "Liraglutide causes massive and rapid reduction of cardiac fat independent of weight loss in type 2 diabetes, " in Proceedings of the 75th American Diabetes Association, Scientific Sessions (ADA '15), vol. 104-LB, Boston, Mass, USA, 2015.
168. E. A. McAninch, T. L. Fonseca, R. Poggioli et al., "Epicardial adipose tissue has a unique transcriptome modified in severe coronary artery disease, " Obesity, vol. 23, no. 6, pp. 1267-1278, 2015.